Skip to main content
. Author manuscript; available in PMC: 2015 Jun 17.
Published in final edited form as: J Neurosci Res. 2012 Jun 20;90(11):2214–2224. doi: 10.1002/jnr.23095

TABLE II.

Concentrations of Other Amino Acids in Central Auditory Regions of Control and Intense-Tone-Exposed Hamsters

Taurine Glutamine Arginine Threonine Serine





Region Control Exposed Control Exposed Control Exposed Control Exposed Control Exposed
AVCN main (9,14) 13.9 ± 1.0 12.7 ± 0.6 26.2 ± 1.8 25.6 ± 1.1 1.2 ± 0.1 1.2 ± 0.1 3.7 ± 0.1 4.1 ± 0.1 4.4 ± 0.5 3.8 ± 0.4
AVCN dorsal (4,6) 14.0 ± 1.4 13.5 ± 0.9 29.8 ± 2.9 27.5 ± 1.9 1.1 ± 0.1 1.2 ± 0.1 4.2 ± 0.4 4.4 ± 0.2 4.2 ± 0.3 3.3 ± 0.6
AVCN subgr (4,6) 17.2 ± 1.4 15.0 ± 1.0 30.2 ± 1.8 28.5 ± 1.3 1.3 ± 0.1 1.4 ± 0.2 4.6 ± 0.3 4.5 ± 0.1 4.0 ± 0.6 4.1 ± 0.6
AVCN gran (6,11) 27.8 ± 1.8 25.0 ± 1.4 38.0 ± 1.6 37.0 ± 1.6 1.7 ± 0.2 2.0 ± 0.2 6.0 ± 0.4 6.7 ± 0.5 5.4 ± 0.9 6.2 ± 0.5
PVCN caudal (13,15) 17.0 ± 0.8* 14.8 ± 0.6 25.9 ± 1.0 26.6 ± 0.8 1.7 ± 0.1 1.6 ± 0.1 4.7 ± 0.2 4.9 ± 0.2 4.6 ± 0.1* 4.2 ± 0.1
PVCN gran (3,4) 31.6 ± 1.7* 22.3 ± 2.5 34.5 ± 2.6 30.6 ± 1.7 1.7 ± 0.3 1.4 ± 0.2 7.0 ± 0.3* 6.0 ± 0.2 6.3 ± 0.8 4.8 ± 0.3
DCN deep (11,12) 16.3 ± 0.8 14.6 ± 0.6 24.9 ± 1.0 25.0 ± 0.9 1.6 ± 0.1 1.5 ± 0.1 5.0 ± 0.2 5.0 ± 0.2 4.1 ± 0.3 3.7 ± 0.1
DCN fus (11,12) 22.2 ± 1.0 19.5 ± 0.8 31.0 ± 0.9 30.0 ± 0.7 1.6 ± 0.1 1.4 ± 0.1 6.2 ± 0.3 6.0 ± 0.2 4.8 ± 0.3 4.0 ± 0.3
DCN mol (11,12) 33.8 ± 0.8 32.3 ± 1.5 40.2 ± 1.4 40.0 ± 1.1 1.4 ± 0.1 1.5 ± 0.1 6.8 ± 0.3 6.7 ± 0.2 6.0 ± 0.4 5.7 ± 0.3
Trapezoid body (4,5) 8.9 ± 0.7 8.2 ± 0.6 10.4 ± 1.0 10.2 ± 0.5 1.3 ± 0.2 1.5 ± 0.2 2.0 ± 0.1 2.1 ± 0.3 2.2 ± 0.5 3.1 ± 0.3
IC dorsal (18,18) 14.0 ± 0.5* 12.3 ± 0.4 29.4 ± 1.2 30.0 ± 1.3 1.0 ± 0.03 1.0 ± 0.03 8.4 ± 0.5 8.3 ± 0.5 2.1 ± 0.1 2.1 ± 0.1
IC ventral (24,24) 11.5 ± 0.2* 10.8 ± 0.2 21.0 ± 0.5 21.6 ± 0.6 1.1 ± 0.02 1.1 ± 0.04 4.8 ± 0.2 4.8 ± 0.2 1.8 ± 0.04 1.8 ± 0.05
IC lateral (16,17) 14.2 ± 0.3 13.4 ± 0.5 25.1 ± 1.0 25.8 ± 1.0 1.1 ± 0.1 1.1 ± 0.02 6.6 ± 0.4 6.6 ± 0.4 2.3 ± 0.1 2.3 ± 0.1
IC medial (6,6) 18.8 ± 0.7 17.3 ± 1.2 40.9 ± 2.5 39.3 ± 1.7 1.0 ± 0.05 1.0 ± 0.04 12.4 ± 0.8 11.8 ± 0.8 2.8 ± 0.2 2.8 ± 0.1
MG dorsal (15,18) 17.1 ± 0.8 15.2 ± 0.8 38.1 ± 0.8 38.1 ± 1.1 0.8 ± 0.03 0.8 ± 0.02 7.9 ± 0.4 8.0 ± 0.3 3.2 ± 0.1 3.3 ± 0.2
MG ventral (20,24) 14.5 ± 0.3*** 12.7 ± 0.3 35.7 ± 1.0 34.3 ± 1.0 0.8 ± 0.03 0.8 ± 0.03 6.7 ± 0.3 6.7 ± 0.2 3.0 ± 0.1 3.0 ± 0.1
MG medial (5,6) 12.2 ± 0.5 11.7 ± 0.3 28.4 ± 1.2 27.5 ± 1.6 0.9 ± 0.1* 1.1 ± 0.1 5.7 ± 0.4 5.8 ± 0.1 3.3 ± 0.7 2.7 ± 0.1
AC layer I (10,12) 37.3 ± 1.4 36.3 ± 1.0 48.1 ± 1.4 50.4 ± 1.7 0.9 ± 0.1 1.0 ± 0.1 13.7 ± 0.7 14.1± 0.7 6.6 ± 0.3 6.0 ± 0.7
AC layer II (10,12) 35.9 ± 1.2 34.6 ± 1.6 47.7 ± 1.6 49.9 ± 2.2 1.0 ± 0.1 0.9 ± 0.1 14.2 ± 0.7 14.8 ± 0.9 6.9 ± 0.5 6.3 ± 0.6
AC layer III (11,13) 33.2 ± 0.9 31.7 ± 1.3 45.6 ± 1.3 46.1 ± 2.0 0.8 ± 0.1 1.0 ± 0.1 13.1 ± 1.4 12.9 ± 0.9 6.0 ± 0.3 5.7 ± 0.6
AC layer IV (10,12) 32.1 ± 1.5 30.7 ± 1.1 44.1 ± 2.0 45.9 ± 2.0 0.9 ± 0.1 0.9 ± 0.1 13.3 ± 1.8 12.9 ± 0.9 5.5 ± 0.7 5.9 ± 0.7
AC layer V (11,12) 29.2 ± 1.5 27.5 ± 1.1 43.6 ± 1.6 45.7 ± 2.1 0.5 ± 0.1 0.7 ± 0.05 10.9 ± 0.7 11.7 ± 0.7 5.2 ± 0.3 5.1 ± 0.4
AC layer VI (11,15) 28.6 ± 1.4 26.1 ± 0.7 42.7 ± 1.6 43.1 ± 1.5 0.7 ± 0.1 0.8 ± 0.04 10.8 ± 0.6 10.8 ± 0.5 5.5 ± 0.3 5.1 ± 0.3
Ext capsule (5,5) 22.1 ± 1.2 22.2 ± 1.3 19.1 ± 0.8 21.4 ± 2.2 1.1 ± 0.1 1.2 ± 0.1 5.7 ± 0.4 6.5 ± 0.6 4.9 ± 0.3 4.5 ± 0.5

Data presentation, numbers of hamsters represented, abbreviations, and numbers of samples assayed as in Table I. Cases with less than the full number of samples are: AVCN gran, eight for serine for exposed; MG ventral, 19 for all except taurine for control and 23 for all except taurine and glutamine for exposed; AC layer II, 11 for serine for exposed; AC layer III, 12 for serine for exposed; AC layer IV, nine for all except taurine for control and 11 for arginine and threonine and 10 for serine for exposed.

*

P < 0.05 control vs. exposed.

***

P < 0.001 control vs. exposed.